Abstract. We investigated the clinical roles and biological function of long non-coding (lncRNA) RPLP0P2 in lung adenocarcinoma (LAD). The expression level of RPLP0P2 was estimated by quantitative reverse transcription-polymerase chain reaction (qPCR) in 57 pairs of LAD and NT samples and the relation of RPLP0P2 to clinical data of LAD patients was analyzed. We overexpressed RPLP0P2 based on the human LAD cell line A549 by lentivirus-mediated technology, then oncological behavior change was observed of A549 cells and the change of mRNA level of LRRC10B and RPLP0P2 by qPCR. We found that RPLP0P2 expression was lower while LRRC10B mRNA level was higher in LAD than NT by qPCR. RPLP0P2 expression level was negative correlated to LRRC10B mRNA level (Pearson correlation =-0.754, P=0.0021). The expression of RPLP0P2 in lymph node metastasis of LAD group was significantly lower than LAD without lymph node metastasis group. Survival analysis showed that survival time of high expression of RPLP0P2 was significantly longer than low RPLP0P2 level in LAD patients. After RPLP0P2 was overexpressed, the proliferation rate, adhesion ability, S phase and G2/M phase cells and LRRC10B mRNA significantly reduced, while apoptosis and G0/G1 phase cells obviously increased, but migration ability and invasion did not significantly change. Our study ascertained that low expression of RPLP0P2 in LAD is associated with poor prognosis and decreased proliferation and adhesion ability of tumor cells. LRRC10B may be a downstream gene regulated by RPLP0P2.
Introduction
Lung cancer is the leading cause of cancer deaths worldwide, and its incidence continues to increase (1) . Non-small cell lung cancer (NSCLC) accounts for ~85% of all lung cancers. Histologically, NSCLC is divided into lung adenocarcinoma (LAD), squamous cell carcinoma (SCC), and large cell carcinoma. Although there has been some progress in chemotherapy, radiation and surgery, lung cancer remains very aggressive and usually rapidly fatal (2) . The average 5-year survival of lung cancer is <15% (3) (4) (5) (6) . In recent years, a growing proportion of LAD is due to socioeconomic development and environmental problems. However, the mechanisms of LAD have not been elucidated.
Studies have shown that lncRNAs are abnormally expressed in tumor cells or tissues and regulate coding gene expression. The altered expression of lncRNAs results in the development, invasion, and metastasis of many cancers with a series of mechanisms (7, 8) . The regulation of gene expression by lncRNAs at the epigenetic level, transcriptional and post-transcriptional level have been reported (9) (10) (11) . LncRNAs have been shown to be involved in the development and progression of lung cancer. However, lung cancer-associated lncRNAs are few including HOTAIR, H19, ANRIL, MALAT1 (12, 13) , SCAL1 (14) , AK126698 (15) , and GAS6-AS1 (16) , so it is very important to identify additional lung cancer-associated lncRNAs and unveil their mechanism of action.
We found that lncRNA RPLP0P2 was downregulated in LAD by high-throughput microarray and real-time quantitative reverse transcription-polymerase chain reaction (qPCR) method in our previous study. Bioinformation analysis showed that LRRC10B might be a target gene regulated by RPLP0P2. However, the clinical roles and biological function of RPLP0P2 are not well understood in LAD. In this study, the expression level of RPLP0P2 was estimated by quantitative PCR in 57 pairs of LAD and NT samples and the relation of RPLP0P2 to clinical data of LAD patients was analyzed. We overexpressed RPLP0P2 based on the human LAD A549 Quantitative PCR. Total RNA was extracted from frozen LAD tissues by using TRIzol reagent (Invitrogen). According to the manufacturer's instructions, total RNA was reverse-transcribed into cDNA using an RT Reagent kit (Takara, Shanghai, China). RPLP0P2 and GAPDH mRNA expression in LAD tissues were measured by quantitative PCR by using SYBR Premix Ex Taq in ABI 7000 instrument. RPLP0P2 sense, 5'-AAAAACGATCAACGAACCTT-3' and antisense, 5'-AAT CGTCTCTGCTTTTCTTG-3'; GAPDH sense, 5'-TGACTT CAACAGCGACACCCA-3' and antisense, 5'-CACCCTGTT GCTGTAGCCAAA-3'; LRRC10B sense, 5'-AAGCCACCG TGCCTCCA-3' and antisense, 5'-TCCCTCGTCCCGTTA TTGC-3'. Total RNA (2 mg) was transcribed to cDNA. PCR was performed in a total reaction volume of 20 µl, including 10 µl of SYBR Premix Ex Taq (2X), 2 µl of cDNA template, 1 µl of PCR forward primer (10 mM), 1 µl of PCR reverse primer (10 mM), and 6 µl of double-distilled water. The quantitative real-time PCR reaction included an initial denaturation step of 10 min at 95˚C; 40 cycles of 5 sec at 95˚C, 30 sec at 60˚C; and a final extension step of 5 min at 72˚C. All experiments were performed in triplicate, and all samples were normalized to GAPDH. The median in each triplicate was used to calculate relative lncRNA concentrations (ΔCt = Ct median lncRNA -Ct median GAPDH), and 2 -ΔΔCt in expression was calculated (17) .
Cell culture. Five human LAD cell lines (SPCA-1, NCI-H1299, A549, NCI-H441, LTEP-a2) were all purchased from the Cell Bank of the Chinese Academy of Sciences and were cultured with complete medium (containing 10% fetal serum and 90% RPMI-1640) set at 37˚C, 5% CO 2 and complete medium was changed at least once every two days.
Lentivirus-mediated overexpression vector transfection.
A549 cells were transfected overexpression vector targeting RPLP0P2 as well as a negative control (GeneChem, Shanghai, China). Transfection was accomplished by seeding 2x10
5 cells into a 6-well plate, and after 24 h, the medium was aspirated and incubated with transfection complex according to the manufacturer's instructions and MOI values (MOI=20). The A549 cells were infected by lentivirus for 72 h and the overexpression efficiency was detected by qPCR.
Cell migration and invasion assays. Migration and invasion assay was performed with 8.0-µm pore inserts (Millipore, uSA) in a 24-well plate. For migration assay, 2x10 4 cells were seeded into the upper compartment of the Transwell inserts. The invasion assay was performed with Matrigel-coated filters (Sigma Corp., USA). Cells were allowed to incubate for 24 and 48 h, respectively. Migrated and invaded were fixed by methanol and stained by 0.1 % (w/v) crystal violet, then bleached with 33% acetic acid and absorbance value measured at 570 nm on a microplate reader. Each experiment was performed in triplicate.
Cell viability assay. Cell viability was evaluated by Cell Counting kit-8 (CCK-8; Corning, Inc., uSA) abiding by the manufacturer's instructions. Briefly, 3,000 cells were resuspended and seeded into a 96-well plate supplemented in the presence of 10% FBS and cultured for a week. The next day, the RPLP0P2 overexpression cells were incubated with CCK-8 for 1 h and the absorbance was measured at 450 nm using a multifunctional microplate reader (Tecan) at day 1, 3, 5 and 7. This experiment was done in quadruplicate cells.
Cell cycle assay. The cells were harvested by centrifugation and fixed by 70% ethanol at 4˚C overnight. The cells were resuspended with 400 µl PBS (containing 2 mg/ml RNA enzymes) and incubated at 37˚C for 30 min, then added 400 µl propidium iodide (0.1 mg/ml) for 10 min and detected DNA content by a flow cytometry analyzer (Cytomics FC 500; Beckman Coulter). The results were analyzed using MultiCycle software.
Adhesion assay. The 96-well plates were processed with 50 µl FN (50 µg/ml), and no processed wells were the CON group. These wells were added into 2x10 4 cells/well and stained by 0.1% (w/v) crystal violet, then dissolved with 2% SDS and detected at OD550 nm. This experiment was done in quadruplicate cells.
Statistical methods. Differences in variables among groups were tested using the one-way ANOVA for the normal distribution or Kruskal-Wallis test for the non-normal distribution. A comparison between the two groups was performed by least significant difference (LSD) test or Student's t-test or Mann-Whitney u test. Survival analysis was performed using Chi-square test. P<0.05 was considered to be statistically significant.
Results

The expression level of RPLP0P2 in lung cancer and adjacent tissues and analysis of its relationship with clinical data.
According to Table I, RPLP0P2 expression level of LAD is 0.287 (0.131-2.96) and significantly lower than its adjacent cancer tissues (Mann-Whitney u =2.120, P=0.0029). We showed that the RPLP0P2 level of LAD with lymph node metastasis was significantly lower than that of LAD without lymph node metastasis group (Mann-Whitney u=9.102, P=0.011). RPLP0P2 expression levels among different clinical stages were not different (Kruskal-Wallis test =7.124, P=0.154). The expression of RPLP0P2 was not relative to the histology differentiation (Kruskal-Wallis test=3.235, P=0.676), smoking (Mann-Whitney u=321.00, P=0.165), or gender (Mann-Whitney u=287.00, P=0.423). LRRC10B mRNA expression level of LAD was significantly higher than its adjacent cancer tissues (Mann-Whitney U=1.530, P=0.000). Pearson correlation analysis showed that RPLP0P2 expression levels were negatively correlated to LRRC10B mRNA levels (Pearson correlation =-0.754, P=0.0021) (Fig. 1) .
RPLP0P2 expression in lung cancer prognosis.
The overall survival time of LAD low expression RPLP0P2 group (median 10 months) was significantly lower than that of the high expression (median 26 months) (χ 2 =18.81, P<0.0001) (Fig. 2) .
The expression level of RPLP0P2 fom five LAD cells.
Compared to normal human bronchial epithelial BEAS-2B cell line, we detected the expression levels of RPLP0P2 from five LAD cell lines (including A549, NCI-H441, NCI-H1299, SPCA-1, LETP-a2) by qPCR. It was shown that the expression levels of RPLP0P2 from LETP-a2, SPCA-1, NCI-H441 cells were highly expressed wherein LETP-a2 was the highest and that of SPCA-1, NCI-H441 were moderately expressed, while that of A549 and NCI-H1299 cells the lowest (Fig. 3) . Therefore, A549 cells were lentivirus-mediated transfection RPLP0P2 overexpression cells.
The expression levels of RPLP0P2 and LRRC10B in three A549 cell groups. The expression levels of RPLP0P2 in three A549 cell groups were different (F=117.00, P<0.0001) and that of overexpression A549 cells was higher than that of the NC group (t=10.34, P=0.0005), control group (t=10.81, Figure 1 . The relative expression levels of RPLP0P2 in lung adenocarcinoma (LAD) and NT tissues. LRRC10B mRNA expression level of LAD was significantly higher than its adjacent cancer tissues ( *** P<0.001). P=0.0004) (Fig. 4) . The LRRC10B mRNA expression levels of three A549 cell groups were different (F=29.11, P=0.0008) and that of RPLP0P2 overexpression A549 cells was lower than that of NC group (t=5.909, P=0.0042), or control group (t=6.056, P=0.0037). While RPLP0P2 expression levels were not changed significantly after LRRC10B siRNA (F= 0.4489, P=0.6582). These experiments hinted that LRRC10B may be a downstream gene regulated by RPLP0P2.
RPLP0P2 is not related to cell migration and invasion.
The OD570 value of three A549 cell groups was not different (F=1.262, P=0.3488), the OD570 value of RPLP0P2 overexpression A549 cells was similar to that of NC group (t=1.715, P=0.153), and control group (t=0.7292, P=0.506) (Fig. 5) . Thus, the cell migration ability of A549 cells did not change after RPLP0P2 was overexpressed. According to Fig. 6 , the OD570 value of the three A549 cell groups was not different (F=0.9129, P=0.4507) the OD570 value of RPLP0P2 overexpression A549 cells was similar to that of NC group (t=0.9879, P=0.3791), and control group (t=1.196, P=0.2979).
RPLP0P2 expression level is associated with cell proliferation and adhesion. Fig. 7 shows the OD450 nm of different A549 groups gradually increased with the change of time. Compared with day 1, the OD450 nm of day 3 (P<0.05, P<0.05, P<0.05), day 5 (P<0.001, P<0.001, P<0.01), day 7 (P<0.001, P<0.001, P<0.001) were significantly increased. Compared with appropriate days of control and NC group, the OD450 nm of 1 and 3 days in RPLP0P2 overexpression group had no statistically significant difference (P>0.05), while that of the 5 days (P<0.05) and the 7 days (P<0.01) significantly reduced, it indicates that cell proliferation ability of A549 was significantly reduced after RPLP0P2 overexpression. Fig. 8 shows that after RPLP0P2 was overexpressed, S phase (P=0.0002 and P=0.0001) and G2/M phase cells (P=0.0004 and P=0.0006) of A549 cells significantly reduced, while apoptosis and G0/G1 phase cells (P=0.0003 and P=0.0007) obviously increased compared to control and NC groups. The cell cycle results further confirmed that the RPLP0P2 expression level was associated with the ability of cell proliferation. The OD550 of control group (P<0.05), NC group (P<0.05) were higher than RPLP0P2 overexpression group among CON group in Fig. 9 . Compared to CON group, the OD550 of control group, NC group from FN processing significantly increased while that of RPLP0P2 overexpression group was not different. Therefore, it was shown that RPLP0P2 lowered the adhesion capacity of A549 cells after overexpression.
Discussion
LncRNAs play an important role in many biological processes, including X chromosome inactivation, gene imprinting (18, 19) and also control gene expression and accelerate the development and progression in cancers (8, 20) . Promoters bind to many transcription factors with mechanisms such as chromosomal rearrangements and transfer elements (21) . An important function of lncRNAs can change the expression of nearby encoding genes by affecting the process of transcription (22) or directly playing an enhancer-like role (23, 24) . Our bioinformation analysis showed that LRRC10B might be a target gene regulated by RPLP0P2. In this study, we uncovered the potential role of RPLP0P2 in the pathogenesis of LAD. We found that RPLP0P2 was lower expressed in LAD by qPCR. The expression of RPLP0P2 in lymph node metastasis of LAD group was significantly lower than LAD without lymph node metastasis group, while it was no relative to TNM stage, degree of tissue differentiation, gender, age, or smoking. Survival time of high expression RPLP0P2 was significantly longer than low RPLP0P2 level in LAD patients, while LRRC10B mRNA level was higher in LAD than NT by qPC. RPLP0P2 expression level negatively correlated to LRRC10B mRNA level. These results hinted that RPLP0P2 is a tumor suppressor and abnormally expressed in LAD.
Compared to normal human bronchial epithelial BEAS-2B cell line, we detected the expression levels of RPLP0P2 from five LAD cell lines. It was shown that the expression levels of RPLP0P2 were highly expressed in LETP-a2, SPCA-1 and NCI-H441, while in A549 and NCI-H1299 cells lowly expressed. In order to further study the mechanism of RPLP0P2 we established RPLP0P2 overexpression of A549 cell line by lentivirus-mediated technology. After RPLP0P2 was overexpressed, the proliferation rate, adhesion ability, S and G2/M phase cells and LRRC10B mRNA significantly reduced, while apoptosis and G0/G1 phase cells obviously increased, but migration ability and invasion did not significantly change.
To summarize, our study ascertained that the expression of RPLP0P2 is downregulated in LAD and is associated with poor prognosis and decreased proliferation and adhesion ability of tumor cells. LRRC10B may be a downstream gene regulated by RPLP0P2.
